DSCSA Compliance

Protecting Patients
Securing Supply Chains

Tri-Pharma maintains full compliance with the Drug Supply Chain Security Act (DSCSA)
as part of our unwavering commitment to pharmaceutical integrity and patient safety.

Our DSCSA Compliance Standards

Tri-Pharma follows strict DSCSA requirements across all levels of our operations:

Tracking and Traceability Overview

DSCSA includes tracking and traceability requirements that aim to enhance the visibility and accountability of prescription drugs throughout the supply chain. These requirements enable effective tracking of product movement and facilitate the tracing of drugs in case of recalls, suspected counterfeit products, or other safety concerns.

Reporting Suspect or Illegitimate Products

Under the Drug Supply Chain Security Act (DSCSA), all entities involved in the pharmaceutical supply chain, including manufacturers, repackagers, wholesale distributors, and dispensers, are required to report suspect or illegitimate products to the Food and Drug Administration (FDA). This reporting requirement is crucial for ensuring patient safety, preventing the distribution of counterfeit or compromised drugs, and maintaining the integrity of the drug supply chain.

Why It Matters

Being DSCSA compliant means:

Our Commitment to You

Compliance and Care First

We don’t just meet the minimum – we go beyond. At Tri-Pharma, we work proactively to stay ahead of regulatory changes and help our clients feel confident in the safety, authenticity, and traceability of every product.